Welcome to our dedicated page for BPCOF news (Ticker: BPCOF), a resource for investors and traders seeking the latest updates and insights on BPCOF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BPCOF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BPCOF's position in the market.
Grounded Lithium Corp. (TSXV: GRD; OTCQB: GRDAF) has signed a Lithium Processing Test Work Program Agreement with Koch Technology Solutions (KTS) to utilize its Li-Pro™ technology for direct lithium extraction (DLE). This testing will take place at a KES facility in Pickering, Ontario, and aims to assess the efficacy of lithium extraction from GLC's brine. The results are anticipated within 6-8 weeks and will inform the selection of optimal extraction technology, which will contribute to a preliminary economic assessment expected by Q2 2023.
Grounded Lithium Corp. (OTCQB: GRDAF) announced its field development plan for the Kindersley Lithium Project (KLP), targeting an initial production of 10,000 metric tons per year. The plan involves 24 producing wells and 5 disposal wells, supported by 70 kilometers of pipelines to minimize surface disturbance. This project is expected to significantly reduce operating costs as it's free of hydrocarbons and H2S, eliminating the need for pre-treatment. The preliminary economic assessment (PEA) is anticipated for Q2 2023, with production expected to commence by 2026. The company also granted stock options and RSUs to employees and insiders.
